Flex Pharma (FLKS) Offers Regulatory, Clinical Update for FLX-787 for Treatment of Nocturnal Leg Cramp

October 13, 2016 6:34 AM EDT Send to a Friend
Flex Pharma, Inc. (NASDAQ: FLKS) today provided a nocturnal leg cramp (NLC) regulatory and clinical update for FLX-787, a topically-acting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login